T 2175/17 (Method of purifying CPS from S. agalactiae/GLAXOSMITHKLINE) of 12.01.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T217517.20220112
- Date of decision
- 12 January 2022
- Case number
- T 2175/17
- Petition for review of
- -
- Application number
- 08864247.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PURIFICATION PROCESSES FOR OBTAINING CPS FROM STREPTOCOCCI
- Applicant name
- GlaxoSmithKline Biologicals SA
- Opponent name
- Pfizer Inc.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 84European Patent Convention Art 87Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Main Request - requirements of the EPC met (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in accordance with claims 1 to 14 of the main request filed with the statement of the grounds of appeal and a description to be adapted.